JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M011664200 on February 21, 2001

J. Biol. Chem., Vol. 276, Issue 23, 20458-20465, June 8, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/23/20458    most recent
M011664200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berton, A.
Right arrow Articles by Emonard, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berton, A.
Right arrow Articles by Emonard, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Involvement of Fibronectin Type II Repeats in the Efficient Inhibition of Gelatinases A and B by Long-chain Unsaturated Fatty Acids*

Alix BertonDagger §, Véronique Rigot||, Eric HuetDagger , Martine DecarmeDagger , Yves Eeckhout, László Patthy**Dagger Dagger , Gaston Godeau§§, William HornebeckDagger , Georges BellonDagger , and Hervé EmonardDagger ¶¶

From the Dagger  CNRS FRE 2260, IFR 53 Biomolecules, Faculty of Medicine, 51 Rue Cognacq Jay, F-51100 Reims, France, the  Cell Biology Unit, Institute of Cellular Pathology and Université catholique de Louvain, B-1200 Brussels, Belgium, the ** Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, H-1518 Budapest, Hungary, and the §§ Laboratory of Biochemistry, Faculty of Odontology, Paris V, F-92120 Montrouge, France

The matrix metalloproteinases gelatinase A (MMP-2) and gelatinase B (MMP-9) are implicated in the physiological and pathological breakdown of several extracellular matrix proteins. In the present study, we show that long-chain fatty acids (e.g. oleic acid, elaidic acid, and cis- and trans-parinaric acids) inhibit gelatinase A as well as gelatinase B with Ki values in the micromolar range but had only weak inhibitory effect on collagenase-1 (MMP-1), as assessed using synthetic or natural substrates. The inhibition of gelatinases depended on fatty acid chain length (with C18 > C16, C14, and C10), and the presence of unsaturations increased their inhibitory capacity on both types of gelatinase. Ex vivo experiments on human skin tissue sections have shown that micromolar concentrations of a long-chain unsaturated fatty acid (elaidic acid) protect collagen and elastin fibers against degradation by gelatinases A and B, respectively. In order to understand why gelatinases are more susceptible than collagenase-1 to inhibition by long-chain fatty acids, the possible role of the fibronectin-like domain (a domain unique to gelatinases) in binding inhibitory fatty acids was investigated. Affinity and kinetic studies with a recombinant fibronectin-like domain of gelatinase A and with a recombinant mutant of gelatinase A from which this domain had been deleted pointed to an interaction of long-chain fatty acids with the fibronectin-like domain of the protease. Surface plasmon resonance studies on the interaction of long-chain fatty acids with the three individual type II modules of the fibronectin-like domain of gelatinase A revealed that the first type II module is primarily responsible for binding these compounds.


* This work was supported in part by a CNRS grant, France, and grants from the Fondation pour la Recherche Médicale, ARERS, Ligue Régionale des Ardennes Contre le Cancer, Région Champagne-Ardennes, the Belgian Fonds de la Recherche Scientifique Médicale, Interuniversity Attraction Poles and Concerted Research Actions of the Université catholique de Louvain.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of a fellowship from Shiseido International France.

|| Postdoctoral fellow of the Christian de Duve Institute of Cellular Pathology (Brussels, Belgium) and of the Association de la Recherche Contre le Cancer, France.

Dagger Dagger Supported by International Center for Genetic Engineering and Biotechnology Grant CRP/HUN98-03 and Hungarian National Research Fund Grant T0022949.

¶¶ To whom correspondence should be addressed: CNRS FRE 2260, Faculté de Médecine, 51 rue Cognacq Jay, 51095 Reims Cedex, France. Tel.: 33-326-91-80-56; Fax: 33-326-91-80-55; E-mail: herve.emonard@univ-reims.fr.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Stem CellsHome page
G. Kasper, J. D. Glaeser, S. Geissler, A. Ode, J. Tuischer, G. Matziolis, C. Perka, and G. N. Duda
Matrix Metalloprotease Activity Is an Essential Link Between Mechanical Stimulus and Mesenchymal Stem Cell Behavior
Stem Cells, August 1, 2007; 25(8): 1985 - 1994.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
C. Chaussain-Miller, F. Fioretti, M. Goldberg, and S. Menashi
The Role of Matrix Metalloproteinases (MMPs) in Human Caries
J. Dent. Res., January 1, 2006; 85(1): 22 - 32.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Emonard, G. Bellon, L. Troeberg, A. Berton, A. Robinet, P. Henriet, E. Marbaix, K. Kirkegaard, L. Patthy, Y. Eeckhout, et al.
Low Density Lipoprotein Receptor-related Protein Mediates Endocytic Clearance of Pro-MMP-2{middle dot}TIMP-2 Complex through a Thrombospondin-independent Mechanism
J. Biol. Chem., December 24, 2004; 279(52): 54944 - 54951.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Wang, G. Takagi, K. Asai, R. G. Resuello, F. F. Natividad, D. E. Vatner, S. F. Vatner, and E. G. Lakatta
Aging Increases Aortic MMP-2 Activity and Angiotensin II in Nonhuman Primates
Hypertension, June 1, 2003; 41(6): 1308 - 1316.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.